General
As the number of COVID-19 cases rises across the US, the New Mexico Department of Health recommends that providers prescribe Paxlovid (nirmatrelvir/ritonavir) to all appropriate patients diagnosed with COVID-19. Paxlovid, an oral antiviral, is a highly effective treatment for COVID-19 but continues to be under prescribed by providers1. Support for the use of Paxlovid comes from several randomized trials and observational studies of symptomatic outpatients with COVID-19, which demonstrated a reduction in hospitalization and death.
LLCP Mission Vision Values handout
NMHSC Stipend Reference Letter for 2023
Talking with Your Children About Cannabis
New HIV infections associated with former VIP Spa in Albuquerque - June 26, 2023
Changes to enrollment cards starting June 16, 2023
New Fingerprinting Service Provider IdentoGO FAQs May 2023
Governors Proclamation Gun Violence Awareness Month 2023
The New Mexico Department of Health has identified five cases of Hantavirus Pulmonary Syndrome (HPS) in New Mexico residents in the first five months of 2023, already exceeding the average annual case count.
Updated SARS-CoV-2/COVID-19 Test Result Reporting Instructions
Introduction to Using Syndromic Surveillance for Monitoring Mental Health-related Indicators
Final Decision Regarding Petition for Insomnia to be included as a qualifying condition for enrollment in the Medical Cannabis Program
This fee schedule will be updated on an annual basis to reflect the most current service payments for the HIV Services Dental Program.
Both the CDC and FDA are reporting national shortages of Benzathine penicillin G (Bicillin L-A®) due to increased demand: FDA Drug Shortages and CDC - STD Treatment - Drug notices. The FDA anticipates the issue will be resolved by the fourth quarter of this year. There are no emergency stockpiles of this medication and existing supplies are very limited.
The New Mexico Department of Health (NMDOH) is seeing low influenza activity statewide and considers the need for seasonal precautions for the prevention of influenza to be over. Moving forward, only occasional and isolated cases of influenza are likely to occur. However, with sporadic influenza activity, it is still possible to see rare summer-time outbreaks of influenza-like illness (ILI), and COVID-19 activity remains unpredictable. ILI is defined as fever of greater than 100° F and cough and/or sore throat in the absence of another known cause. An influenza outbreak is defined as one confirmed case of influenza (by PCR test) and any other cases of ILI in the same geographic location. Since flu circulation is likely to be low outside of the main respiratory season, any rapid positive influenza results should be confirmed by PCR before declaring an outbreak. Outbreaks should be reported to the on-call epidemiologist 24/7/365 at (505) 827-0006.
Department of Public Safety Announcement Letter April 10, 2023
Department of Public Safety Announcement Letter April 17, 2023
Department of Public Safety Announcement Letter April 21, 2023